WEBSITECHANGES

Website Changes

---

12/02/2025

Imvax Announces Positive Top-line Data from Phase 2b Clinical Trial of IGV-001 in Newly Diagnosed GBM

---

12/01/2025

One of the world`s oldest blood pressure drugs may also halt aggressive brain tumor growth

---

12/01/2025

Musella Foundation 2025 Highlights

---

12/01/2025

Glioblastoma immunotherapy trial: a new breakthrough

---

11/15/2025

Bacteria Inside Brain Tumors Could Affect How They Behave

---

11/04/2025

Servier Announces Positive Findings from Longer-Term Analysis of Phase 3 INDIGO Trial Showing Continued Durable Effect of Voranigo

---

11/03/2025

Upcoming webinar!

---

11/03/2025

FLAG Therapeutics Secures Over $500,000 in Equity and Impact Funding from Venture and Mission-Driven Investors, Including Springhood Ventures, Kids Beating Cancer, The Musella Foundation, the AYJ Fund, Tough2gether Foundation and DDRFA

---

10/27/2025

Share Your Experiences With Glioblastoma (GBM)

---

10/27/2025

Sonodynamic Therapy Using 5-Aminolevulinic Acid for Malignant Gliomas: A Review

---

10/27/2025

Breakthrough clinical trial confirms that GammaTile delivers superior tumor control compared to standard of care for patients with newly diagnosed operable brain metastases

---

10/27/2025

Banner MD Anderson begins Phase II study on unique glioblastoma immunotherapy

---

10/21/2025

Share Your Experience If You Have a BRAF-Mutated Brain Tumor

---

10/20/2025

Biomarker analysis includes clues to long-term survival in glioblastoma patients treated with SurVaxM

---

10/20/2025

Upcoming webinar!

---

10/17/2025

Glioma Leptomeningeal Disease: Cytarabine Under Investigation

---

10/13/2025

Novocure to Present Final Results from the Pivotal Phase 3 METIS Trial of its Tumor Treating Fields (TTFields) Therapy for Brain Metastases from Non-Small Cell Lung Cancer at 2025 ASTRO Annual Meeting

---

10/13/2025

Innovative system accurately detects genetic mutations in the brain tumor within 25 minutes

---

10/13/2025

Upcoming webinar!

---

10/13/2025

NuvOx and FYR Bio Announce NCI Funding for Liquid Biopsy Collaboration Supporting NuvOx’s Phase IIb Glioblastoma Trial

---

09/29/2025

Guiding principles for adult CNS tumor treatment programs

---

09/29/2025

The 25th Annual UCLA Brain Tumor Conference will now be online!

---

09/22/2025

Dispersed Glioblastoma Cells Prove More Aggressive

---

09/22/2025

Investigational Drug Tinostamustine to be Included in GBM AGILE Clinical Trial for Glioblastoma

---

09/15/2025

Reminder - Webinar Thursday!

---